...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Confused

Toniv,

Thanks for the continued discussion. I think you summed it up nicely. There is still confusion, and like you I hope that Jan 7th brings clarity. Happy holidays to all.

BearDownAZ

Share
New Message
Please login to post a reply